[2-[(3S,5R,8R,9S,10S,13R,14S,17R)-14-hydroxy-10,13-dimethyl-17-(6-oxopyran-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl]-2-pyrrolidin-1-ylethyl] hydrogen carbonate

C31H45NO6 — CID 67349874

IUPAC[2-[(3S,5R,8R,9S,10S,13R,14S,17R)-14-hydroxy-10,13-dimethyl-17-(6-oxopyran-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl]-2-pyrrolidin-1-ylethyl] hydrogen carbonate
SMILESC[C@]12CC[C@H](C(COC(=O)O)N3CCCC3)C[C@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](c3ccc(=O)oc3)CC[C@]12O
InChIInChI=1S/C31H45NO6/c1-29-12-9-20(26(19-38-28(34)35)32-15-3-4-16-32)17-22(29)6-7-25-24(29)10-13-30(2)23(11-14-31(25,30)36)21-5-8-27(33)37-18-21/h5,8,18,20,22-26,36H,3-4,6-7,9-17,19H2,1-2H3,(H,34,35)/t20-,22+,23+,24-,25+,26?,29-,30+,31-/m0/s1
InChIKeyHUZFXWQHGDIZSK-QNANPZGMSA-N
MW527.70 g/mol
LogP5.66
Rot. Bonds5

About [2-[(3S,5R,8R,9S,10S,13R,14S,17R)-14-hydroxy-10,13-dimethyl-17-(6-oxopyran-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl]-2-pyrrolidin-1-ylethyl] hydrogen carbonate

[2-[(3S,5R,8R,9S,10S,13R,14S,17R)-14-hydroxy-10,13-dimethyl-17-(6-oxopyran-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl]-2-pyrrolidin-1-ylethyl] hydrogen carbonate (PubChem CID 67349874) has the molecular formula C31H45NO6 and a molecular weight of 527.70 g/mol. Its IUPAC name is [2-[(3S,5R,8R,9S,10S,13R,14S,17R)-14-hydroxy-10,13-dimethyl-17-(6-oxopyran-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl]-2-pyrrolidin-1-ylethyl] hydrogen carbonate.

Molecular Properties

Compound Name[2-[(3S,5R,8R,9S,10S,13R,14S,17R)-14-hydroxy-10,13-dimethyl-17-(6-oxopyran-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl]-2-pyrrolidin-1-ylethyl] hydrogen carbonate
PubChem CID67349874
Molecular FormulaC31H45NO6
Molecular Weight527.70 g/mol
Exact Mass527.32
IUPAC Name[2-[(3S,5R,8R,9S,10S,13R,14S,17R)-14-hydroxy-10,13-dimethyl-17-(6-oxopyran-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl]-2-pyrrolidin-1-ylethyl] hydrogen carbonate
SMILESC[C@]12CC[C@H](C(COC(=O)O)N3CCCC3)C[C@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](c3ccc(=O)oc3)CC[C@]12O
InChIInChI=1S/C31H45NO6/c1-29-12-9-20(26(19-38-28(34)35)32-15-3-4-16-32)17-22(29)6-7-25-24(29)10-13-30(2)23(11-14-31(25,30)36)21-5-8-27(33)37-18-21/h5,8,18,20,22-26,36H,3-4,6-7,9-17,19H2,1-2H3,(H,34,35)/t20-,22+,23+,24-,25+,26?,29-,30+,31-/m0/s1
InChIKeyHUZFXWQHGDIZSK-QNANPZGMSA-N
XLogP5.66
TPSA100.21 Ų
H-Bond Donors2
H-Bond Acceptors6
Rotatable Bonds5
Heavy Atoms38
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500527.70
LogP ≤ 55.66
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 106

Analyze [2-[(3S,5R,8R,9S,10S,13R,14S,17R)-14-hydroxy-10,13-dimethyl-17-(6-oxopyran-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl]-2-pyrrolidin-1-ylethyl] hydrogen carbonate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [2-[(3S,5R,8R,9S,10S,13R,14S,17R)-14-hydroxy-10,13-dimethyl-17-(6-oxopyran-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl]-2-pyrrolidin-1-ylethyl] hydrogen carbonate?
The IUPAC name of [2-[(3S,5R,8R,9S,10S,13R,14S,17R)-14-hydroxy-10,13-dimethyl-17-(6-oxopyran-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl]-2-pyrrolidin-1-ylethyl] hydrogen carbonate (CID 67349874) is [2-[(3S,5R,8R,9S,10S,13R,14S,17R)-14-hydroxy-10,13-dimethyl-17-(6-oxopyran-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl]-2-pyrrolidin-1-ylethyl] hydrogen carbonate.
What is the SMILES notation for [2-[(3S,5R,8R,9S,10S,13R,14S,17R)-14-hydroxy-10,13-dimethyl-17-(6-oxopyran-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl]-2-pyrrolidin-1-ylethyl] hydrogen carbonate?
The canonical SMILES for [2-[(3S,5R,8R,9S,10S,13R,14S,17R)-14-hydroxy-10,13-dimethyl-17-(6-oxopyran-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl]-2-pyrrolidin-1-ylethyl] hydrogen carbonate is C[C@]12CC[C@H](C(COC(=O)O)N3CCCC3)C[C@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](c3ccc(=O)oc3)CC[C@]12O.
What is the InChIKey of [2-[(3S,5R,8R,9S,10S,13R,14S,17R)-14-hydroxy-10,13-dimethyl-17-(6-oxopyran-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl]-2-pyrrolidin-1-ylethyl] hydrogen carbonate?
The InChIKey is HUZFXWQHGDIZSK-QNANPZGMSA-N. The full InChI is InChI=1S/C31H45NO6/c1-29-12-9-20(26(19-38-28(34)35)32-15-3-4-16-32)17-22(29)6-7-25-24(29)10-13-30(2)23(11-14-31(25,30)36)21-5-8-27(33)37-18-21/h5,8,18,20,22-26,36H,3-4,6-7,9-17,19H2,1-2H3,(H,34,35)/t20-,22+,23+,24-,25+,26?,29-,30+,31-/m0/s1.
What are the key properties of [2-[(3S,5R,8R,9S,10S,13R,14S,17R)-14-hydroxy-10,13-dimethyl-17-(6-oxopyran-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl]-2-pyrrolidin-1-ylethyl] hydrogen carbonate?
[2-[(3S,5R,8R,9S,10S,13R,14S,17R)-14-hydroxy-10,13-dimethyl-17-(6-oxopyran-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl]-2-pyrrolidin-1-ylethyl] hydrogen carbonate has a molecular weight of 527.70 g/mol, XLogP of 5.66, 5 rotatable bonds, 2 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for [2-[(3S,5R,8R,9S,10S,13R,14S,17R)-14-hydroxy-10,13-dimethyl-17-(6-oxopyran-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl]-2-pyrrolidin-1-ylethyl] hydrogen carbonate is sourced from PubChem (CID 67349874), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).